TAT-327
TAT-327 is cell-penetrating peptide. TAT-327 selectively inserts into cancer cell membranes and shows potent antitumor activity. TAT-327 effectively inhibits cancer cells proliferation, induces apoptosis and disrupts EGFR signal pathway by inhibiting downstream signals (such as IL-2, TNF-α and IFN-γ) expression and the Eps8/EGFR interaction. TAT-327 significantly inhibits tumor growth in HT-29 xenograft mcie models.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C109H181N41O25S
- Masse moléculaire:2497.93
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform EGFR
MoreVoir tous les produits spécifiques à Isoform TNF Receptor
More
Activité biologique
Description
Chemical Information
-
Masse moléculaire 2497.93
-
Formule C109H181N41O25S
-
Sequence
Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Glu-Phe-Leu-Asp-Cys-Phe-Gln-Lys-Phe
-
Sequence Shortening
RKKRRQRRREFLDCFQKF
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- TAT-327
- TAT327
- TAT 327
- EGFR
- IFNAR
- Interleukin Related
- TNF Receptor
- Complement System
- Apoptosis
- Epidermal growth factor receptor
- ErbB-1
- HER1
- Interferon-α/β receptor
- Interferon-alpha/beta receptor
- IL
- Tumor Necrosis Factor Receptor
- TNFR
- Cell-penetrating peptide
- Antitumor
- A549 cells
- Colo320 cells
- HepG2 cells
- HT-29 cells
- HT-29 xenograft mcie models
- Inhibitor
- inhibitor
- inhibit